{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:17Z","timestamp":1793141837326,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10147-025-02870-7","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:23:33Z","timestamp":1757607813000},"page":"2375-2386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal nationwide analysis of uveal melanoma in the United States 1995\u20132018"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0930-4583","authenticated-orcid":false,"given":"Ahmad Samir","family":"Alfaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-7894","authenticated-orcid":false,"given":"Mohamed H.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-8476","authenticated-orcid":false,"given":"Moataz Hamed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2870_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ijc.20690","volume":"114","author":"A Stang","year":"2005","unstructured":"Stang A, Parkin DM, Ferlay J et al (2005) International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int J Cancer 114:114\u2013123. https:\/\/doi.org\/10.1002\/ijc.20690","journal-title":"Int J Cancer"},{"key":"2870_CR2","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L et al (2007) Incidence of uveal melanoma in Europe. Ophthalmology 114:2309-2315.e2. https:\/\/doi.org\/10.1016\/j.ophtha.2007.01.032","journal-title":"Ophthalmology"},{"key":"2870_CR3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK (2011) Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118:1881\u20131885. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.040","journal-title":"Ophthalmology"},{"key":"2870_CR4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00417-021-05317-7","volume":"260","author":"AS Alfaar","year":"2022","unstructured":"Alfaar AS, Saad A, Wiedemann P et al (2022) The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. Graefes Arch Clin Exp Ophthalmol 260:1723\u20131731. https:\/\/doi.org\/10.1007\/s00417-021-05317-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2870_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3614039","volume":"2020","author":"Y Xu","year":"2020","unstructured":"Xu Y, Lou L, Wang Y et al (2020) Epidemiological study of uveal melanoma from US surveillance, epidemiology, and end results program (2010\u20132015). J Ophthalmol 2020:3614039. https:\/\/doi.org\/10.1155\/2020\/3614039","journal-title":"J Ophthalmol"},{"key":"2870_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000480640","volume":"4","author":"ME Aronow","year":"2018","unstructured":"Aronow ME, Topham AK, Singh AD (2018) Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973\u20132013). Ocul Oncol Pathol 4:145\u2013151. https:\/\/doi.org\/10.1159\/000480640","journal-title":"Ocul Oncol Pathol"},{"key":"2870_CR7","unstructured":"\u2019National Cancer Institute, DCCPS SRP (2017) Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2018 Sub (1975\u20132016) <Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969\u20132017"},{"key":"2870_CR8","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1007\/s10792-022-02406-2","volume":"42","author":"A Alfaar","year":"2022","unstructured":"Alfaar A, Saad A, Chlad P et al (2022) Uveal melanoma and marital status: a relationship that affects survival. Int Ophthalmol 42:3857\u20133867. https:\/\/doi.org\/10.1007\/s10792-022-02406-2","journal-title":"Int Ophthalmol"},{"key":"2870_CR9","unstructured":"(2021) North American Association of Central Cancer Registries (NAACCR). https:\/\/www.naaccr.org\/"},{"key":"2870_CR10","unstructured":"National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. In: NPCR SEER Incid. - U.S. Cancer Stat. 2001\u20132017 Public Use Res. Database, 2019 Submiss. (2001\u20132017). Released June 2020. www.cdc.gov\/cancer\/uscs\/public-use"},{"key":"2870_CR11","volume-title":"International classification of diseases for oncology, 3rd edition (ICD-O-3)","author":"A Fritz","year":"2000","unstructured":"Fritz A, Percy C, Jack A et al (2000) International classification of diseases for oncology, 3rd edition (ICD-O-3). World Health Organization, Lyon, France"},{"key":"2870_CR12","unstructured":"National Cancer Institute (2015) Surveillance Research Program, National Cancer Institute SEER*Stat software"},{"key":"2870_CR13","unstructured":"Microsoft Corp. (2021) Microsoft Excel. Version 16.0.13801.20360. https:\/\/www.microsoft.com\/en-us\/microsoft-365\/excel. Accessed 3 Apr 2021"},{"key":"2870_CR14","doi-asserted-by":"crossref","unstructured":"Tableau-Software (2020) Tableau Desktop Version 2020.1.2. https:\/\/www.tableau.com\/. Accessed 11 Oct 2020","DOI":"10.1007\/978-3-319-32001-4_196-1"},{"key":"2870_CR15","unstructured":"OpenStreetMap. https:\/\/www.openstreetmap.org\/. Accessed 20 May 2021"},{"key":"2870_CR16","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1158\/1055-9965.EPI-21-0423","volume":"30","author":"AB Mariotto","year":"2021","unstructured":"Mariotto AB, Zhang F, Buckman DW et al (2021) Characterizing trends in cancer patients\u2019 survival using the JPSurv software. Cancer Epidemiol Biomarkers Prev 30:2001\u20132009. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-0423","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2870_CR17","first-page":"1","volume":"47","author":"RN Anderson","year":"1998","unstructured":"Anderson RN, Rosenberg HM (1998) Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 47:1\u201316 (20)","journal-title":"Natl Vital Stat Rep"},{"key":"2870_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0962280206070621","volume":"15","author":"RC Tiwari","year":"2006","unstructured":"Tiwari RC, Clegg LX, Zou Z (2006) Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 15:547\u2013569. https:\/\/doi.org\/10.1177\/0962280206070621","journal-title":"Stat Methods Med Res"},{"key":"2870_CR19","volume-title":"Applied regression analysis and other multivariable methods","author":"D Kleinbaum","year":"1988","unstructured":"Kleinbaum D, Kupper LL, Muller KE (1988) Applied regression analysis and other multivariable methods, 2nd edn. PWS-Kent, Boston","edition":"2"},{"key":"2870_CR20","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(sici)1097-0142(19981015)83:8<1664::aid-cncr23>3.0.co;2-g","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83:1664\u20131678. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19981015)83:8%3c1664::aid-cncr23%3e3.0.co;2-g","journal-title":"Cancer"},{"key":"2870_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/09286580591000836","volume":"12","author":"P Isager","year":"2005","unstructured":"Isager P, \u00d8sterlind A, Engholm G et al (2005) Uveal and conjunctival malignant melanoma in Denmark, 1943\u201397: incidence and validation study. Ophthalmic Epidemiol 12:223\u2013232. https:\/\/doi.org\/10.1080\/09286580591000836","journal-title":"Ophthalmic Epidemiol"},{"key":"2870_CR22","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1167\/iovs.03-0081","volume":"44","author":"L Bergman","year":"2003","unstructured":"Bergman L, Seregard S, Nilsson B et al (2003) Uveal melanoma survival in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 44:3282\u20133287. https:\/\/doi.org\/10.1167\/iovs.03-0081","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2870_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40942-020-00261-w","volume":"6","author":"E Lucena","year":"2020","unstructured":"Lucena E, Goldemberg DC, Thuler LCS et al (2020) Epidemiology of uveal melanoma in Brazil. Int J Retin Vitr 6:51. https:\/\/doi.org\/10.1186\/s40942-020-00261-w","journal-title":"Int J Retin Vitr"},{"key":"2870_CR24","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1136\/bjophthalmol-2018-312966","volume":"103","author":"FM Ghazawi","year":"2019","unstructured":"Ghazawi FM, Darwich R, Le M et al (2019) Uveal melanoma incidence trends in Canada: a national comprehensive population-based study. Br J Ophthalmol 103:1872\u20131876. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312966","journal-title":"Br J Ophthalmol"},{"key":"2870_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000492391","volume":"5","author":"C Baily","year":"2019","unstructured":"Baily C, O\u2019Neill V, Dunne M et al (2019) Uveal melanoma in Ireland. Ocul Oncol Pathol 5:195\u2013204. https:\/\/doi.org\/10.1159\/000492391","journal-title":"Ocul Oncol Pathol"},{"key":"2870_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/a:1023002322935","volume":"14","author":"PA Wingo","year":"2003","unstructured":"Wingo PA, Jamison PM, Hiatt RA et al (2003) Building the infrastructure for nationwide cancer surveillance and control\u2013a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 14:175\u2013193. https:\/\/doi.org\/10.1023\/a:1023002322935","journal-title":"Cancer Causes Control"},{"key":"2870_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227197","volume":"14","author":"C-H Hsu","year":"2019","unstructured":"Hsu C-H, Chan JK, Yin C-H et al (2019) Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS ONE 14:e0227197. https:\/\/doi.org\/10.1371\/journal.pone.0227197","journal-title":"PLoS ONE"},{"key":"2870_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10552-016-0790-x","volume":"27","author":"T-M Kuo","year":"2016","unstructured":"Kuo T-M, Mobley LR (2016) How generalizable are the SEER registries to the cancer populations of the USA? Cancer Causes Control 27:1117\u20131126. https:\/\/doi.org\/10.1007\/s10552-016-0790-x","journal-title":"Cancer Causes Control"},{"key":"2870_CR29","first-page":"288","volume":"23","author":"JB Yu","year":"2009","unstructured":"Yu JB, Gross CP, Wilson LD et al (2009) NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) 23:288\u2013295","journal-title":"Oncology (Williston Park)"},{"key":"2870_CR30","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2147\/OPTH.S113623","volume":"10","author":"K Mahendraraj","year":"2016","unstructured":"Mahendraraj K, Lau CS, Lee I et al (2016) Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973\u20132012). Clin Ophthalmol 10:2113\u20132119. https:\/\/doi.org\/10.2147\/OPTH.S113623","journal-title":"Clin Ophthalmol"},{"key":"2870_CR31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","volume":"110","author":"AD Singh","year":"2003","unstructured":"Singh AD, Topham A (2003) Incidence of uveal melanoma in the United States: 1973\u20131997. Ophthalmology 110:956\u2013961. https:\/\/doi.org\/10.1016\/S0161-6420(03)00078-2","journal-title":"Ophthalmology"},{"key":"2870_CR32","unstructured":"Registry Groupings in SEER Data and Statistics - SEER Registries. https:\/\/seer.cancer.gov\/registries\/terms.html. Accessed 14 Oct 2021"},{"key":"2870_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3109\/08820538.2016.1154176","volume":"31","author":"EE Nichols","year":"2016","unstructured":"Nichols EE, Richmond A, Daniels AB (2016) Disparities in uveal melanoma: patient characteristics. Semin Ophthalmol 31:296\u2013303. https:\/\/doi.org\/10.3109\/08820538.2016.1154176","journal-title":"Semin Ophthalmol"},{"key":"2870_CR34","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1167\/iovs.16-20077","volume":"58","author":"SJ Park","year":"2017","unstructured":"Park SJ, Oh C-M, Yeon B et al (2017) Sex disparity in survival of patients with uveal melanoma: better survival rates in women than in men in South Korea. Invest Ophthalmol Vis Sci 58:1909\u20131915. https:\/\/doi.org\/10.1167\/iovs.16-20077","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2870_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1515\/sjph-2016-0012","volume":"55","author":"V Zadnik","year":"2016","unstructured":"Zadnik V, \u017dagar T, Primic \u017dakelj M (2016) Cancer patients\u2019 survival: standard calculation methods and some considerations regarding their interpretation. Slov J Public Health 55:144\u2013151. https:\/\/doi.org\/10.1515\/sjph-2016-0012","journal-title":"Slov J Public Health"},{"key":"2870_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/ijc.2910630303","volume":"63","author":"CTM Schrijvers","year":"1995","unstructured":"Schrijvers CTM, Mackenbach JP, Lutz J-M et al (1995) Deprivation, stage at diagnosis and cancer survival. Int J Cancer 63:324\u2013329. https:\/\/doi.org\/10.1002\/ijc.2910630303","journal-title":"Int J Cancer"},{"key":"2870_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canep.2019.04.005","volume":"60","author":"MJ Rutherford","year":"2019","unstructured":"Rutherford MJ, Andersson TM-L, Bj\u00f6rkholm M et al (2019) Loss in life expectancy and gain in life years as measures of cancer impact. Cancer Epidemiol 60:168\u2013173. https:\/\/doi.org\/10.1016\/j.canep.2019.04.005","journal-title":"Cancer Epidemiol"},{"key":"2870_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1001799","author":"S Conte","year":"2023","unstructured":"Conte S, Lagac\u00e9 F, Ghazawi FM et al (2023) Uveal melanoma incidence trends in Canada: 1992\u20132010 vs. 2011\u20132017. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.1001799","journal-title":"Front Med"},{"key":"2870_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/01.cej.0000197453.79733.a6","volume":"15","author":"A Stang","year":"2006","unstructured":"Stang A, Schmidt-pokrzywniak A, Lehnert M et al (2006) Population-based incidence estimates of uveal melanoma in Germany. Supplementing cancer registry data by case-control data. Eur J Cancer Prev 15:165\u2013170. https:\/\/doi.org\/10.1097\/01.cej.0000197453.79733.a6","journal-title":"Eur J Cancer Prev"},{"key":"2870_CR40","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/bjophthalmol-2015-306810","volume":"99","author":"MT Andreoli","year":"2015","unstructured":"Andreoli MT, Mieler WF, Leiderman YI (2015) Epidemiological trends in uveal melanoma. Br J Ophthalmol 99:1550\u20131553. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306810","journal-title":"Br J Ophthalmol"},{"key":"2870_CR41","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.1990.01070110084030","volume":"108","author":"A Vine","year":"1990","unstructured":"Vine A, Sneed S, Elner V et al (1990) Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. Arch Ophthalmol 108:1268\u20131273. https:\/\/doi.org\/10.1001\/archopht.1990.01070110084030","journal-title":"Arch Ophthalmol"},{"key":"2870_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081075","author":"L Frizziero","year":"2019","unstructured":"Frizziero L, Midena E, Trainiti S et al (2019) Uveal melanoma biopsy: a review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11081075","journal-title":"Cancers (Basel)"},{"key":"2870_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ijc.2910610606","volume":"61","author":"AJ Swerdlow","year":"1995","unstructured":"Swerdlow AJ, Storm HH, Sasieni PD (1995) Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943\u20131989. Int J Cancer 61:773\u2013779. https:\/\/doi.org\/10.1002\/ijc.2910610606","journal-title":"Int J Cancer"},{"key":"2870_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000990","volume":"5","author":"AS Alfaar","year":"2020","unstructured":"Alfaar AS, Saad A, Elzouki S et al (2020) Uveal melanoma-associated cancers revisited. ESMO Open 5:e000990. https:\/\/doi.org\/10.1136\/esmoopen-2020-000990","journal-title":"ESMO Open"},{"key":"2870_CR45","doi-asserted-by":"publisher","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, et al (2005) Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No 25 Arch Ophthalmol (Chicago Ill 1960) 123:601\u20134. https:\/\/doi.org\/10.1001\/archopht.123.5.601","DOI":"10.1001\/archopht.123.5.601"},{"key":"2870_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/s0197-2456(01)00113-1","volume":"22","author":"CS Moy","year":"2001","unstructured":"Moy CS, Albert DM, Diener-West M et al (2001) Cause-specific mortality coding. methods in the collaborative ocular melanoma study coms report no. 14. Control Clin Trials 22:248\u2013262. https:\/\/doi.org\/10.1016\/s0197-2456(01)00113-1","journal-title":"Control Clin Trials"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02870-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02870-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02870-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:05:42Z","timestamp":1762923942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02870-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2870"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02870-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}